Elizabeth K. Ziemke

机构：University of Michigan · ORCID：0000-0002-8612-7891

发表论文 82 篇 · 总被引 294 次 · h-index 7

代表论文

A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance (2024 · Nature Cancer · 被引 21)
Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence (2023 · Molecular Cancer Therapeutics · 被引 12)
Abstract 1230: MTX-531, a first-in-class pan-PI3K inhibitor spares hyperinsulinemia yielding durable tumor regressions and resilience to adaptive resistance (2024 · Cancer Research · 被引 1)
Targeting casein kinase 1α-mediated FADD phosphorylation restores sensitivity in select CDK4/6 inhibitor-resistant breast cancer models (2026 · Journal of Clinical Investigation)
Supplementary Dataset S5 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition (2025)
Supplementary Dataset S3 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition (2025)